Portfolio map · Asset manager · United States
Blue Owl portfolio map
38 startups Blue Owl has backed in rounds we track, since 2018, grouped by their main sector. Together they have raised $71B; Blue Owl led at least one round in 2 of them. The biggest sector is Biotech, with 15 companies.
38startups backed
4sectors
$71Braised between them
Biotechbiggest sector
Biotech
15
Fintech
10
Funding by segment
- Biotech$5.1B15
- Fintech$7.5B10
- AI$57B8
- Pharma$1.3B5
Where they are based
- United States29$56B
- United Kingdom6$13B
- Switzerland1$365M
- Canada1$1.7B
- South Africa1$500M
United States
United Kingdom
Switzerland
Canada
South AfricaFounded
6Earlier
212
313
214
415
216
117
918
119
120
121
22
23
124
125
26
4 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M3
- $50M to $250M15
- $250M to $1B12
- $1B and over8
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
33 of 38 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States29
- United Kingdom6
- Switzerland1
- Canada1
- South Africa1
Startups by country, 5 countries in all.
Segment by segment
Biotech
15 startups · $5.1B raised
BridgeBioBridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.United States$1.4B
CelcuityCelcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.United States$1.0B
Windward BioWindward Bio is a clinical-stage biotechnology company with deep discovery, development, and commercialization expertise committedSwitzerland$365M
Star TherapeuticsStar Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California, founded in 2018.United States$325M
Cardurion PharmaceuticalsCardurion Pharmaceuticals is a clinical-stage biotechnology company founded in 2017, focused on developing innovative therapeuticsUnited States$260M
Mirador TherapeuticsMirador Therapeutics is a clinical-stage precision medicine company based in San Diego, California.United States$250M
Obsidian TherapeuticsObsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.United States$210M
Palvella TherapeuticsPalvella Therapeutics is a clinical-stage biopharmaceutical company based in Wayne, Pennsylvania.United States$210M
Fintech
10 startups · $7.5B raised
FinastraFinastra provides the broadest portfolio of financial services software.United Kingdom$5.3B
Capital on TapCapital on Tap is a fintech company that provides small businesses with credit cards and a spend management platform.United Kingdom$654M
VestwellVestwell is a financial technology company based in New York City, founded in 2016.United States$553M
PointPoint Card is a financial tool that offers debit, overdraft facility, and credit card-like features.United States$427M- CCommonBondUnited States$219M
- AAllicaUnited Kingdom$155M
Juniper SquareJuniper Square is a fintech company based in San Francisco, founded in 2014.United States$108M
Finance of America CompaniesFinance of America Companies is a consumer lending company that offers lending products and services.United States$50M
AI
8 startups · $57B raised
DatabricksDatabricks is a data and AI company that provides a unified, cloud-based platform designed for data analytics, artificial intelligUnited States$34B
CrusoeCrusoe is an energy-first AI infrastructure company that develops and operates large-scale, AI-optimized data centers powered by cUnited States$9.9B- NNscaleUnited Kingdom$6.9B
GroqGroq, Inc.United States$3.2B
ClioLexicata is now part of the Clio family.Canada$1.7B
Ayar LabsAyar Labs is a semiconductor company focused on transforming AI infrastructure through high-speed, light-based optical I/O solutions.United States$904M- PPerkSouth Africa$500M
6sense6sense arms revenue team with the data and visibility that needs to create and convert pipeline into revenue.United States$159M
Pharma
5 startups · $1.3B raised
MapLight TherapeuticsMapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.United States$523M
Madrigal PharmaceuticalsMadrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.United States$350M
Cullinan TherapeuticsCullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.United States$280M
Scholar RockScholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.United States$167M
ImageneBioImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseasesUnited States$30M
How this map is made. Every startup here has raised money in a round we track that names Blue Owl as an investor, the first in 2018. Each sits under its main sector, read from its rounds, and each sector shows its best-funded first; sectors with fewer than three companies are left off. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosAsset manager · United StatesBlackRock145 startups · 12 sectors · $585BAsset manager · United StatesPerceptive Advisors133 startups · 4 sectors · $28BAccelerator · United StatesY Combinator2,679 startups · 12 sectors · $111BVC firm · United StatesTechstars1,119 startups · 12 sectors · $16BGovernment fund · United StatesNational Science Foundation988 startups · 12 sectors · $10BAngel investor · United States500 Global757 startups · 12 sectors · $21B
Raising from investors like Blue Owl?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.